Bohai Pharmaceutical (fka BOPH)

[dfh]

I'm kind of thinking that the slowdown in China isn't our problem here. Medicinal sales are not too affected in slowdowns. I think the uncertainty of the financing arrangement of the acquisition, lack of the auditing arrangement they said would happen, and their obliviousness or ineptness of the website being down has worried investors, including myself. The one danger sign I don't see here is no pumping. So, who knows?